Price Geoffrey M's Form 4/A amendment
AmendedOak Street Health, Inc. (OSH) · filed Mar 22, 2023
- Accession no.
- 0001209191-23-020595
- Filed
- Mar 22, 2023
- Trade date
- Mar 15, 2023
- Filing delay
- 7 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Mar 17, 2023
This filing lists 1 non-derivative transaction. It carries over 5 transactions from the original filing that it did not restate. Open-market sales total $2.91M. It was filed 7 days after the trade.
This amendment restates part of 0001209191-23-019904 (filed Mar 17, 2023). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Price Geoffrey MCIK 0001793313 | Director, Officer (Chief Innovation Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2023 | Common Stock, $0.001 par value | MOption exerciseAcquired | +1,831 | $21.00 | +$38,451 | 3,880,262 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001209191-23-019904 (filed Mar 17, 2023).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −1,831 | $35.60 | −$65,183.6 | 3,874,769 | Direct | |
| Mar 16, 2023 | Common Stock, $0.001 par value | MOption exerciseAcquired | +79,858 | $21.00 | +$1,677,018 | 3,954,627 | Direct | |
| Mar 16, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −79,858 | $35.62F2 | −$2,844,541.96 | 3,874,769 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2023 | Common Stock, par value $0.001 | MOption exerciseDisposed | −1,831 | $21.00 | −$38,451 | 1,917,052 | Direct | |
| Mar 16, 2023 | Common Stock, par value $0.001 | MOption exerciseDisposed | −79,858 | $21.00 | −$1,677,018 | 1,837,194 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F2
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.60 - $35.70, inclusive. The Reporting Person undertakes to provide to Oak Street Health, Inc., any security holder of Oak Street Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote (2).
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- F2
On March 17, 2023, the Reporting Person filed a Form 4 reporting the exercise of stock options and the sale of the resulting shares issued upon that exercise. Due to an administrative error, this acquisition was erroneously reported as a disposition resulting in the number of securities reported as beneficially owned being understated by 3,662 shares. This amendment is being filed to correct that error.